GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Boston Scientific Corporation (BSX) [hlAlert]

Rating:
Outperform
BSX
up 123.18 %

Boston Scientific Corporation (BSX) upgraded to Outperform by Credit Suisse

Posted on: Friday,  Apr 26, 2013  8:25 AM ET by Credit Suisse

Credit Suisse rated Outperform Boston Scientific Corporation (NYSE: BSX) on 04/26/2013, when the stock price was $7.59. Since
then, Boston Scientific Corporation has gained 123.19% as of 10/28/2015's recent price of $16.94.
If you would have followed this Credit Suisse's recommendation on BSX, you would have gained 123.18% of your investment in 915 days.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/26/2013 8:25 AM Buy
None
7.59
as of 12/13/2013
1 Week down  -3.88 %
1 Month down  -4.52 %
3 Months down  -3.80 %
1 YTD up  70.02 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/3/2013 8:25 AM Hold
None
7.75
1/15/2013 8:25 AM Buy
None
6.46
2/12/2010 10:25 AM Hold
None
7.32 8.50
10/20/2009 11:25 AM Hold
None
8.62 11.50
2/5/2009 9:25 AM Hold
None
9.08 9.50
11/7/2007 11:25 AM Hold
None
12.90 15.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy